Abstract
To the Editor: Mucous membrane pemphigoid (MMP) represents a group of chronic and progressive subepithelial blistering disorders.1 Although much of the existing literature is focused on treatment of high-risk sites such as conjunctival mucosa, oral involvement is the most common and can cause significant dysfunction.2 Additionally, long-term uncontrolled inflammation may lead to dental caries and loss of alveolar bone.3 Topical corticosteroids are first-line therapy for mild and slowly progressive oral MMP but can be difficult to apply and/or may provide inadequate relief.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
